This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Sox9 protein enables molecular 'time travel' that can lead to colorectal cancer

Sox9 protein enables molecular time travel that can lead to colorectal cancer
Elevated expression of Sox9 and reduced expression of differentiation genes in murine models of intestinal neoplasia. A. Diagram showing breeding scheme to achieve Lgr5-Apcf/f-tdT mice for conditional Apc inactivation. B. Representative images showing gross anatomy of duodenal intestines from indicated mice. C. Heat map of intestinal stem cell (red) and differentiation (blue) genes from previously published mouse models (Dow et al., 2015). RNA-seq data from the following three mice with and without dox are presented: shRNA against Renilla, Apc (shApc) alone or in combination with mutant K-ras allele. D. High magnification representative images of Sox9 overexpression in dysplastic crypts of AOM/DSS model (left); quantification of Sox9 positivity from three lesions. E. High magnification representative images of Sox9 overexpression in carcinoma from MNU model; scale bar = 250 μM. Credit: Science Advances (2023). DOI: 10.1126/sciadv.adf0927

Normally the lining of the colon forms a series of steep hills and valleys. At the surface, where the hills peak, are functional colon cells that do the organ's work of absorption and secretion. Deep in the valleys are stem cells that constantly renew those functional cells. New research from Dana-Farber Cancer Institute found that the cells in those valleys can go through a transition before cancer begins.

Using mouse models and tumor models called patient-derived organoids, they found that the cells undergo a type of molecular time travel that reverts them back to an embryonic state. Fetal genes that are silenced in adults are inappropriately turned on, endowing greater cellular flexibility. But instead of creating functional cells that migrate to the surface, they create immature, non-functional cells that clump together to form benign growths called adenomas. Over time, these adenomas can turn cancerous.

Over 80% of colorectal cancers show signs of mutations that are related to this immature state of impaired differentiation. The researchers also found that this molecular time travel depends on a protein called Sox9 and that blocking Sox9 in mouse models prevented adenoma formation, enabled cells to mature, and resulted in the death of pre-cancer cells. The work builds on previous research from the Sethi Lab at Dana-Farber suggesting that human colon cancer depends on Sox9.

Approximately 80% of harbor mutations that interrupt , resulting in the buildup of immature pre-cancerous cells. These insights, however, have not resulted in clinically effective medicines. This study looks at what happens before the emergence of these mutations and finds not only evidence of fetal reprogramming that can initiate , but also a protein, Sox9, that fuels that reprogramming. This and previous research from the Sethi Lab suggest Sox9 is a promising therapeutic target for .

The paper is published in the journal Science Advances.

More information: Pratyusha Bala et al, Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation, Science Advances (2023). DOI: 10.1126/sciadv.adf0927. www.science.org/doi/10.1126/sciadv.adf0927

Journal information: Science Advances

Citation: Sox9 protein enables molecular 'time travel' that can lead to colorectal cancer (2023, March 29) retrieved 29 May 2023 from https://medicalxpress.com/news/2023-03-sox9-protein-enables-molecular-colorectal.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A stem cell protein facilitates relapse of pediatric brain tumors

136 shares

Feedback to editors